Plaque-targeted, proteolysis-resistant, activatable and MRI-visible nano-GLP-1 receptor agonist targets smooth muscle cell differentiation in atherosclerosis

Background: Glucagon-like peptide-1 receptor (GLP-1R) agonists are powerful glycemia-lowering agents, which have systematically been shown to lower cardiovascular events and mortality. These beneficial effects were difficult to pinpoint within atherosclerotic plaque due to lack of particular specifi...

Descripción completa

Detalles Bibliográficos
Autores principales: Maiseyeu, Andrei, Di, Lin, Ravodina, Anastasia, Barajas-Espinosa, Alma, Sakamoto, Atsushi, Chaplin, Alice, Zhong, Jixin, Gao, Huiyun, Mignery, Matthew, Narula, Navneet, Finn, Aloke V., Rajagopalan, Sanjay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8965488/
https://www.ncbi.nlm.nih.gov/pubmed/35401813
http://dx.doi.org/10.7150/thno.66456

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8965488/
https://www.ncbi.nlm.nih.gov/pubmed/35401813
http://dx.doi.org/10.7150/thno.66456

Ejemplares similares